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ABSTRACT 
	
EFFECTS OF TWO HIGH-FREQUENCY PHYSICAL THERAPY 
PROGRAMS ON BALANCE, GAIT, FATIGUE, AND QUALITY OF 
LIFE IN PEOPLE WITH MULTIPLE SCLEROSIS 
Min Liu, M.S.  
University of Nebraska Medical Center, 2018 
 
Supervisors: Ka-Chun Siu, Ph.D. and Max J. Kurz, Ph.D. 
Multiple sclerosis (MS) is an inflammatory disease involving the inflammation and 
demyelination in both brain and spinal cord. MS typically affects people in early 
adulthood in the range of 20-40 years old, and most patients with MS experience 
symptoms on a daily basis, such as walking difficulties, balance impairment, and fatigue, 
which can be disabling and impact the Quality of Life (QOL).  
The main purpose of this investigation is to determine if our novel, adaptive, high-
frequency physical therapy protocol, compared with the conventional therapeutic exercise 
protocol, has the potential to improve participants’ dynamic balance, gait, fatigue, and 
overall QOL based on clinical measurement scales. After the completion of this 
investigation, we found that both types of protocols with the same high dosage improved 
the balance, gait, fatigue, and QOL in people with MS similarly in a clinically relevant 
manner. Our results provide evidence that a high-frequency physical therapy intervention 
consisting of twice per day and five days per week sessions may be an important 
parameter for improving balance, gait, fatigue, and QOL in people with MS.  
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Chapter 1 Introduction 
Background  
Triggered by environmental and genetic factors, multiple sclerosis (MS) is a chronic 
immune-mediated disease involving inflammation, plaques, and demyelination in the 
central nervous system.1 Clinically, there are four subdivisions of MS, including 
Relapsing-Remitting MS (RRMS), Secondary-Progressive MS (SPMS), Primary-
Progressive MS (PPMS), and Clinically Isolated Syndrome (CIS).2 RRMS is 
characterized by self-limited acute attacks of neurologic dysfunction developing from 
days to weeks. Then most patients experience a recovery of function over the next few 
weeks to months. Between attacks, those patients can be clinically stable. The second 
type, SPMS, begins as RRMS, but its clinical course is characterized by a steady 
deterioration in function unrelated to acute neurologic attacks. Unlike SPMS, the third 
one, PPMS starts with a steady increase in disability from the very beginning without 
acute attacks. The fourth type, CIS, refers to a first episode of MS-related symptoms 
lasting at least 24 hours caused by inflammatory demyelination in the central nervous 
system that may or may not continue to develop MS. MS typically affects people in early 
adulthood in the 20-40 year range and is two to three times more common in women than 
men.3 MS affects approximately 400,000 people in the United States and 2.1 million 
people worldwide.4,5 As a costly chronic disease, the total all-cause health care costs 
associated with MS including direct and indirect costs ranged from $8,528 to $52,244 per 
patient per year in the US.6 Common symptoms of MS include fatigue, gait difficulties, 
impaired balance, spasticity, depression, and cognitive impairment.7 Most patients with 
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MS experience symptoms on a daily basis, especially balance impairment, which can be 
disabling and impact the Quality of Life (QOL).8,9 Although pharmacological 
interventions play an important role in the treatment of these symptoms, a physical 
rehabilitation approach is also imperative as it may target the dysregulation of the 
inflammatory balance in MS, but its effectiveness remains elusive.10 
   There is increasing evidence to support that exercise training may yield beneficial 
effects on the mobility and balance function of individuals with MS.11-13 Exercise training 
for MS includes aerobic exercises, resistance exercises, and other nontraditional exercise 
training, such as yoga, Tai chi, and Pilates.13-16 Although various exercise training 
methods were used, there is no universal model of training for individuals with MS.17 The 
frequency of exercise training in existing literature ranged from mild to moderate, with 
most experiments conducted between 30-90 minutes per session, 2-4 times per week. For 
example, Motl et al.18 performed a combined training therapy with a maximum of 60 
minutes in duration and 3 days per week. Others recommended 20-30 minutes of aerobic 
exercise more than 3 days per week.19 Collectively, these investigations showed a small 
improvement of symptoms in people with MS.11,20 It remains to be established what type 
of training method is optimal, how many times a week a person should train, and how 
long a training session should last for people with MS.  
    Previously we conducted two studies using two types of protocols with high frequency 
physical therapy and demonstrated that the high frequency of physical therapy protocol 
may be beneficial to people with MS in regards to mobility, postural balance, and motor 
control of the ankle plantarflexors.21,22 One adaptive physical therapy protocol in our 
studies was performed at a higher dosage (two times per day, five days per week as 
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compared to more traditional levels of two to three sessions per week), and progressively 
challenged the patient’s balance, in hopes of making it more adaptable to unstable 
situations. Exemplary therapies include forcing patients to use the more impaired limbs 
and directing the patient’s attention towards focusing on how to adapt their movement 
patterns. Moreover, the therapeutic dosage in our study (45 minutes per session, twice a 
day, 5 days a week for a 6-week period) was larger than previous studies23,24 (typically 2-
4 times per week for 30-60 minutes over a 3-12 week period). We suspected that our 
high-frequency physical therapy protocol would have clinically relevant improvements in 
gait, balance, fatigue, and QOL in MS as well, based on different clinical measurements. 
Purpose 
The primary purpose of this investigation is to determine if our novel, adaptive, high-
frequency physical therapy protocol, compared with the conventional therapeutic exercise 
protocol, has the potential to improve participants’ dynamic balance, gait ability, fatigue, 
and overall QOL based on clinical measurement scales. Specifically, the Dynamic Gait 
Index (DGI) is used to assess the dynamic walking balance; Twelve-Item MS Walking 
Scale (MSWS-12) for gait ability; Modified Fatigue Impact Scale (MFIS) for fatigue, and 
Multiple Sclerosis Impact Scale (MSIS-29) for overall QOL. 
Research Hypothesis 
Hypothesis 1:  
Compared with the group who completed traditional therapeutic exercise protocol, the 
group that completed novel motor adaptive therapeutic protocol will have greater 
improvements in the DGI score after 6 weeks of therapy.   
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Hypothesis 2: 
The MSWS-12 score will be improved in the group that completed novel motor adaptive 
therapeutic protocol than the group who completed traditional therapeutic exercise 
protocol after 6 weeks of therapy.  
Hypothesis 3: 
The group that completed novel motor adaptive therapeutic protocol will improve fatigue, 
based on the MFIS score, compared with the group who completed traditional therapeutic 
exercise protocol after 6 weeks of therapy.  
Hypothesis 4: 
The group that completed novel motor adaptive therapeutic protocol will have a 
decreased MSIS-29 score than the group who completed traditional therapeutic exercise 
protocol after 6 weeks of therapy.  
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Chapter 2 Literature Review 
Multiple Sclerosis 
	
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease in the central 
nervous system. Several factors have been proposed to explain the pathogenesis of MS, 
including genetic susceptibility, infectious agents, and other environmental factors. 
Pathological hallmarks of MS include focal or diffused plagues of demyelination, 
inflammation, axonal loss, and neurodegeneration in brain and spinal cord. Over time, 
repeated pathological episodes of disease activity in CNS can lead to a wide range of 
clinical features of MS, such as weakness, fatigue, gait instability, balance impairments, 
cognitive deficits, visual and sensory changes. Such symptoms often result in poor 
Qualify of Life (QOL). The clinical characteristics and disability levels vary significantly 
among individuals with MS. Kurtzke Expanded Disability Status Scale (EDSS) has been 
established and gained its international acceptance to measure MS severity, and it is 
graded as mild (0–3.5), moderate (4–5.5) and severe (6–10).25 The EDSS measures the 
degree of neurologic impairments within eight functional domains including pyramidal, 
cerebellar, brain stem, sensory, bladder and bowel, visual, cerebral and other. There is 
increasing evidence that physical therapy or exercise training may have beneficial effects 
on people with MS. In this review, we focus on four areas of clinical characteristics to 
investigate the effects of physical therapy on MS, based on data from previous clinical 
trials as discussed below.  
 
Balance impairment and effects of physical therapy interventions on balance in MS  
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One of the primary manifestations in MS patients is the balance impairment. Balance 
dysfunction can lead to falls, injury, and reduced activity participation.26 It is estimated 
that around 74% of people with MS have difficulty with the balance and 50% of MS 
patients felt balance impairment limited their ability to perform activities of daily 
living.27 A study also suggests that individuals with MS may even experience motor 
function deterioration during the early stages of the disease with no clinical neurologic 
signs.28 Balance maintenance requires the interaction of visual, vestibular, and 
proprioception processes to generate coordinated movements that maintain the center of 
mass within the limits of stability. One study reveals that the delay in postural response is 
the result of the slowed somatosensory conduction.29 People with MS have poor 
performance in the functional reach test, arm raise test, tandem stance, single-leg stance, 
and in response to external perturbation.30 Specifically for standing posture balance, 
compared with healthy adults, individuals with MS have decreased ability to maintain 
position and have more postural sway, which leads to increased risks of falling.31,32 And 
for dynamic balance, people with MS move less far and less quickly towards limits of 
stability when trying to reach or step.28,32,33 MS patients also demonstrate reduced center 
of pressure displacement during voluntary leaning and reaching.33 Moreover, people with 
MS have less ability to control anticipatory and reactive balance. A few studies indicate 
that there are trunk control deficits and delayed posture responses to postural 
displacements and perturbations, as well as reduced ability to control anterior-posterior 
sway in response to these perturbations in people with MS.29,34 Cameron et al. suggests 
that the primary cause of imbalance in MS is the result of slowed afferent proprioceptive 
conduction in the spinal cord, unlike the imbalance from cerebellar disorders.29 
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     The Dynamic Gait Index (DGI) is a commonly used tool in rehabilitation settings to 
assess dynamic balance while adapting gait to changes in task demands, including gait on 
even surfaces, gait while changing speed, gait while performing head turns, stepping 
over, or around obstacles, and pivoting during walking and stair climbing. The total score 
ranges from 0 to 24. A high score indicates better performance on dynamic balance. A 
score of 19 or less has been shown to be associated with higher risk of falls in MS.35,36 
The DGI is a reliable tool to assess balance and gait dysfunction in persons with MS, 
with inter-rater reliability ranging from .910 to .976, and intra-rater reliability ranging 
from .760 to .986.35 It also has excellent criterion validity with other balance scales in 
people with MS, such as Timed Up and Go (TUG), Berg Balance Scale (BBS), and 
Activities-specific Balance Confidence (ABC).37  
     There are limited studies determining the therapeutic exercise effects on balance in 
MS. Several randomized controlled trials (RCT) demonstrated mixed results on balance 
in people with MS through various training exercises, including combined aerobic and 
resistance exercise38-40, aquatic training41, and group stability exercise, based on the 
standard measures, such as TUG, DGI, BBS, and Functional Reach test (FR).42 
Specifically, combined resistance and aerobic training were found to have a small, but 
non-significant effect on balance in people with MS.39,40 Specific balance exercises were 
also conducted in one RCT. Cattaneo et al.43 demonstrated that specific balance retraining 
exercises had a significant effect on balance in individuals with MS, based on the BBS, 
but no significant effect observed on the DGI. Another RCT also suggested that the group 
exercise program was effective in improving the balance in patients with MS, based on 
the BBS.44 The intervention consisted of flexibility, range of motion, strengthening for 
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low extremity, core stabilization, balance and coordination, and functional activities, 60 
min per session, 3 times a week for 12 weeks.44 Overall, the frequency of the exercise 
training in the previous studies ranged from mild to moderate, spreading between 3-10 
weeks, 3-8 sessions per week, 30-60 min/session, which has been shown to yield 
significant, but small improvements on balance in patients with MS.23 Therefore, the 
evidence regarding the beneficial effects of physical therapy interventions on balance in 
MS is still weak and it is based on a limited number of non-RCTs and RCTs.  
 
Gait dysfunction and relevant physical therapy interventions in people with MS  
	
Gait abnormalities are common in individuals with MS and associated with increased 
likelihood of experiencing falls and reduced quality of life. Gait disturbance can be seen 
in early stages of the disease, even identified in patients with the absence of gait 
abnormalities on standard clinical examination.45 About 85% of people with MS indicate 
gait disturbances as their main complaint.46 A study reported that approximately 33% of 
patients with MS had difficulty walking and required assistance at 10 years from the 
onset of MS.47 While the exact causes of gait abnormalities observed in MS are yet to be 
identified, it is believed that lower extremity weakness, spasticity, and sensory changes 
may contribute to the symptoms. People with MS tend to walk slower, have decreased 
step length and cadence, spend a greater percentage of a gait cycle in double support, and 
demonstrate less joint motion and more variability in gait parameters during gait than 
healthy controls.46,48,49 A recent study also revealed that individuals with MS showed 
decreased range of motion at the ankle, knee, and hip associated with increased pelvic tilt 
and hiking.50 Allali et al. suggested gait analysis, such as stride time variability, 
		
	
9	
represents a clinical potential predictor of falls in people with MS with low disability, and 
it may be more appropriate than the EDSS in studies focused on fall prevention in MS.51  
    The 12-item Multiple Sclerosis Walking Scale (MSWS-12) is a MS-specific, patient-
based questionnaire to measure the gait ability in individuals with MS in clinical studies 
and clinical practice. Each item ranges from 1 to 5, generating total scores ranging from 
12 to 60, or transformed scores ranging from 0-100, with the higher the sum is, the more 
severe the degree of ambulatory disability. It is a highly valid and reliable scale in 
MS.52,53 A study reported that MSWS-12 is significantly correlated with spatiotemporal 
parameters of gait in people with MS, suggesting that it is an easily administered and 
inexpensive tool for the comprehensive assessment of walking disability in individuals 
with MS.54  
    There is emerging evidence that physical therapy interventions can ameliorate gait 
dysfunction in people with MS. Several studies focused on specific interventions for 
muscle weakness, spasticity, and reduced gait velocity that contribute to gait 
abnormalities in MS, including resistance training, aerobic exercise, and body weight-
supported treadmill training (BWSTT).18,55-58 Resistance training has shown to improve 
functional mobility based on the 10-meter walk test (10MWT) and 6-minute walk test 
(6MWT).57 Resistance training can also improve gait kinematics, including increased step 
length, stride length, and foot angle, as well as decreased duration of the double-support 
phase.56  
Aerobic exercise is another type of training program and it has been shown to 
improve walking speed and endurance in patients with MS.58 BWSTT can provide 
aerobic training for patients with severe MS who are not able to walk independently on a 
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treadmill, and it is suggested that BWSTT may improve walking speed and endurance in 
people with severe MS.59 Moreover, ankle foot orthoses and functional electrical 
stimulation have been demonstrated to improve the gait pattern of individuals with MS 
and to reduce the energy expenditure while walking.60,61 The frequency of interventions 
in most aforementioned studies is mild to moderate, ranging from 2-5 times/week, 20-60 
minutes/session for 4-8 weeks.  
    In summary, there is promising evidence supporting that some types of physical 
therapy interventions may improve gait/walking abilities in patients with MS. However, 
it is insufficient to determine optimal dosage and whether patients can tolerate the high-
frequency physical therapy intervention.  
 
Fatigue and related physical therapy interventions in individuals with MS 
	
Fatigue is also considered to be one of the most common symptoms and disabling 
features of MS62, with 65-97% of individuals having  significant fatigue63 and 15-40% 
reporting fatigue as the most disabling symptom.64 Fatigue in MS is an abnormal sense of 
tiredness or lack of energy, out of proportion to the degree of effort or level of energy, 
which significantly interferes with daily activities. The manifestation of fatigue in MS 
includes acute fatigue related to specific muscle groups and global, persistent fatigue 
which adversely affects both mental and physical activity.65 Prolonged fatigue associated 
with localized muscles may lead to weakness, and it should not be confused with 
weakness. There are two different types of fatigue in MS, including mental (central) 
fatigue, inability to sustain the central drive to spinal motor neurons, and motor 
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(peripheral) fatigue, a loss of force-generating capacity within the muscle itself. MS 
fatigue can also be categorized into primary fatigue and secondary fatigue. Primary 
fatigue is believed to be directly related to the central nervous system damage specific to 
MS, such as demyelination, inflammation, and axonal loss. Secondary fatigue may be 
attributed to pain, depression, stress, anxiety, sleep disorders, medication use, and general 
deconditioning. The pathophysiology of central fatigue in people with MS is not well 
understood and probably related to the demyelination, diffuse cerebral axonal injury, 
brain atrophy, reduced cortical metabolic activity, and inflammation.66-68 Two studies 
have shown that anatomical and metabolic muscle changes may contribute to the 
symptoms of peripheral fatigue in people with MS, including less Type I (fatigue 
resistant) fibers, more Type II (fatigable) fibers, decreased fiber size, oxidative capacity 
impairments, and slowed excitation-contraction responses.69,70 Both peripheral and 
central mechanisms may have some roles in the pathogenesis of fatigue in MS. However, 
it is believed that central mechanisms plays a more important role.71 Fatigue may also be 
related to gait variability in MS. Sehle et al.72 suggested that gait variability is 
significantly correlated with the motor sections of the Fatigue Scale of Motor and 
Cognition, but not with the cognitive portion of the scale, which indicates that motor 
fatigue is more related to gait variability than mental fatigue. Kalron73 also found that a 
fatigued group walked slower, took smaller steps, and had a shorter stride length than 
those in a non-fatigued group. However, two other studies reported that there were 
minimal associations between fatigue and gait variability during short walks.46,74 There is 
also a relationship between fatigue and balance in MS. A study demonstrated that fatigue 
was significantly associated with balance as a function of central sensory integration in 
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people with MS.75 Collectively, fatigue is one of the common symptoms of MS. Fatigue 
may be associated with other clinical features, such as gait and balance. It is complex and 
not fully understood, which warrants further study. 
    An accurate assessment of fatigue is beneficial to help clinicians and researchers 
determine the severity of fatigue. The Modified Fatigue Impact Scale (MFIS) is a clinical 
measurement to evaluate fatigue in MS.76 The MFIS is based on items derived from 
interviews with patients with MS regarding how fatigue impacts their lives. It consists of 
21 items, with each item scoring between 0 and 4, which gives a self-reported 
multidimensional measure of fatigue on physical, cognitive, and psychosocial 
functioning. The MFIS global score range is between 0 and 84, with a higher score 
indicating more fatigue. Reliability and validity of the MFIS have been established in 
people with MS and it has been recommended as an outcome measure for use in MS 
research and clinical practice.77 
    The treatment of fatigue mainly includes pharmacologic and non-pharmacologic 
therapies. There are a few medications, including Amantadine, Modafinil, and 
Armodafinil, which may mitigate the fatigue symptom in persons with MS, however, no 
effective medicine has been found.68 On the other hand, therapeutic exercise may be an 
alternative way to reduce fatigue and appears to be more effective in improving fatigue 
compared to the pharmacological agents.78 A recent Cochrane systematic review 
demonstrated that exercise therapy is a promising way to reduce fatigue without harm in 
patients with MS, based on the results of the 45 RCTs.24 The frequency in these studies is 
relatively low to moderate, ranging from 30 to 60 minutes per session, 2 to 5 times per 
week, with the duration of the interventions ranged from 8 to 12 weeks.24 A few studies 
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also explored the effects of high intensity exercises on people with MS.57,79-83 A recent 
exploratory study suggested that high-intensity resistance training is associated with 
clinical improvements in fatigue in people with relapsing remitting multiple sclerosis, 
possibly through its positive effects on decreased pro-inflammatory cytokine levels.81 
This high-intensity intervention was performed twice a week, 60 min per session for 12 
weeks, with a 5 min warm-up, three lower body exercises, four upper body exercises, and 
one whole body exercise in each training.81 One RCT also showed that 12 weeks of 
high-intensity aerobic training combined with resistance training was safe and well 
tolerated, with improved muscle strength and endurance capacity in MS.82 However, 
another RCT revealed that the standard training including aerobic exercises, lower 
extremity stretching, upper extremity strength training, and balance exercises, with the 
addition of high-intensity eccentric muscle training, was not superior to the standard 
training alone, regarding fatigue, balance, and gait assessments, after the intervention of 
45-60 min per session, 3×/week for 12 weeks.83 Collectively, some types of exercise 
training may improve symptomatic fatigue in persons with MS, but the optimal 
therapeutic paradigm to treat the MS-related fatigue is still yet to be determined.  
 
Quality of Life (QOL) and related physical therapy interventions in MS 
	
QOL is an umbrella term that includes social, emotional, physical, economic and cultural 
dimensions of our lives. There is emerging evidence that QOL is compromised in patients 
with MS.84,85 Several factors, including physical disability status, fatigue, depression, age, 
sex, and socioeconomic status, have been found to be associated with lower QOL in 
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people with MS than healthy populations or patients with other chronic diseases.86 
Statistical results have shown that the unemployment rate is up to 70% in community-
dwelling individuals with MS, and half of them due to the MS consequences.87 After the 
initial diagnosis, at least a third of MS patients experience a significant decline in their 
standard of living.88 Compromised QOL in MS is also associated with the severity of the 
disease, which has been found to correlate with high economic burden to society.89 
Therefore, it is imperative for clinicians to find a way to improve QOL in patients with 
MS. 
    The Multiple Sclerosis Impact Scale (MSIS-29)90 is one of the most common 
questionnaires to measure QOL in people with MS. It is a twenty-nine item, disease-
specific scale to access the impact of MS from the patient’s perspective. It consists of 20 
physical items and 9 psychological items that may impact individuals with MS. This is 
consistent with the definition of health-related QOL incorporating both psychological and 
physical components.91 The MSIS-29 ranges between 29 and 145, with higher scores 
indicating greater impact or a poor quality of life. It is a valuable outcome measurement, 
used not only in cross-sectional studies but also in intervention studies to monitor MS 
progression.92 A minimal change of 8 points in the MSIS-29 indicates clinical 
significance.93  
    Exercise training is a promising intervention for improving QOL in MS. Fatigue, 
disability, depression, pain, social support, and self-efficacy act as intermediary roles 
between physical training and QOL.94 There is cumulative evidence supporting that 
physical exercise is associated with a small improvement in QOL in people MS.95 
However, the parameters of the exercise training protocols on QOL, such as the type of 
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exercise training, the length of the intervention, and the amount of the training per week, 
vary considerably in existing literatures. A study reports that there is a significant effect 
for aerobic exercise on improving QOL in MS, but not for non-aerobic exercise or 
aerobic and non-aerobic exercise combined.95 Exercise training interventions of  < 3 
months and interventions of ≥ 3 months both are associated with significant 
improvements in QOL, but shorter duration of interventions are associated with greater 
effects.95 This research also suggests that exercise training greater than 90 minutes per 
week yields greater effects on QOL than that of less than 90 minutes per week.95 Thus, 
various exercise training protocols and small treatment effect on QOL underscore the 
importance of establishing the optimal therapeutic paradigm to improve QOL in MS.  
Summary 
	
    In summary, there is supportive, but not overwhelming evidence for a beneficial effect 
of physical therapy and exercise training on gait, balance, fatigue, and QOL. The average 
duration of the existing training protocols was 60 minutes per session (30-90) lasting 
9 weeks (range 3–24) with a mean frequency of 3 sessions per week (range 2–6). Existing 
physical therapy training protocols include resistance exercise, aerobic exercise, 
combined aerobic and resistance training, and alternative interventions, such as aquatics, 
yoga, Tai chi, etc. The participants in the majority of existing clinical trials have mild to 
moderate level of disability based on the EDSS.  In spite of the emerging evidence 
supporting the beneficial effects of physical therapy interventions on gait, balance, 
fatigue, and QOL in people with MS, the heterogeneity of protocols and participant 
samples with various levels of severities in previous studies raises questions regarding the 
optimal components and frequency of training, such as type of exercises, optimal 
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duration of training, and number of sessions required to elicit significant and clinically 
relevant improvements. Our previous investigations showed that a high frequency of 
physical therapy was beneficial to people with MS in regards to walking speed, step 
length, walking endurance, postural balance, and motor control of the ankle 
plantarflexors21,22. We suspected that our high-frequency physical therapy protocol would 
have clinically relevant improvements in gait, balance, fatigue, and QOL in MS as well, 
based on different clinical measurements.  
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Chapter 3: Manuscript 
	
Introduction 
Multiple sclerosis (MS) is an inflammatory disease involving the inflammation and 
demyelination in both brain and spinal cord.1,96 MS typically affects people in early 
adulthood in the 20-40 year range and is two to three times more common in women than 
men.3 MS affects approximately 400,000 people in the United States and 2.1 million 
people worldwide.4,5 As a costly chronic disease, the total health care costs associated 
with MS including direct and indirect costs ranged from $8,528 to $52,244 per patient per 
year in the US.6 Common symptoms of MS include fatigue, gait difficulties, impaired 
balance, spasticity, depression, and cognitive impairment.7 Most patients with MS 
experience symptoms on a daily basis, especially balance impairment, which can be 
disabling and impact the Quality of Life (QOL).8,9 Although pharmacological 
interventions play an important role in the treatment of these symptoms, physical 
rehabilitation approach is also imperative as it may target the dysregulation of the 
inflammatory balance in MS, but its effectiveness remains elusive.10 
     There is increasing evidence to support that exercise training may yield beneficial 
effects on the balance and mobility function of individuals with MS.11-13 Exercise training 
for MS includes aerobic exercises, resistance exercises, and other nontraditional exercise 
training, such as yoga, Tai chi, and Pilates.13-16 Although various exercise training 
methods were used, there is no universal model of training targeting specific impairment 
in individuals with MS, and it is typically driven by personal preferences.17 The 
frequency of exercise training in existing literature ranged from mild to moderate, with 
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most experiments conducted between 30-90 minutes per session, 2-4 times per week. For 
example, Motl et al.18 performed a combined training therapy incorporating aerobic, 
resistance, and balance exercises with a maximum of 60 minutes in duration and 3 days 
per week. Others recommended 20-30 minutes of aerobic exercise more than 3 days per 
week.19 Collectively, these investigations showed a small improvement of symptoms in 
people with MS.11,20 It remains to be established what is the optimal exercise regimen, 
such as what type of training method is best, how many times a week a person should 
train, and how long a training session should last for people with MS.  
    Previously we conducted studies using two types of protocols with high frequency 
physical therapy and demonstrated that the high frequency of physical therapy protocol 
may be beneficial to people with MS in regards to mobility, postural balance, and motor 
control of the ankle plantarflexors.21,22 One adaptive physical therapy protocol in our 
studies was performed at a higher dosage, and constantly challenged the patient’s 
balance, in hopes of making it more adaptable to unstable situations. Exemplary therapies 
include forcing patients to use the more impaired limbs and directing the patient’s 
attention towards focusing on how to adapt their movement patterns. Moreover, the 
therapeutic dosage in our study (45 minutes per session, twice a day, 5 days a week for a 
6-week period) was larger than previous studies23,24 (typically 2-4 times per week for 30-
60 minutes over a 3-12 week period). We anticipated that our high-frequency physical 
therapy protocol would have clinically relevant improvements in gait, balance, fatigue, 
and QOL in MS as well, based on different clinical measurements. 
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Methods 
 
Participants  
	
Thirty-three participants were recruited from the University of Nebraska Medical 
Center’s (UNMC) MS clinic with the following inclusion criteria: between 30-70 years 
old, a Kurtzke Expanded Disability Status Score (EDSS) of 3.0-6.5, a definitive diagnosis 
of MS, able to walk on a treadmill at a minimum speed of 0.5 miles per hour while 
holding onto handrails, cognitively competent, and a Mini-Mental State Examination 
score of >21. The exclusion criteria were: documented MS-related relapse in the previous 
six months, major MS-specific medication changes in the previous three months, and the 
presence of another major co-morbidity such as neurological disorders, uncontrolled pain, 
hypertension, and diabetes. The study was reviewed and approved by the UNMC 
Institutional Review Board, and all participants provided written consent (clinical trial 
registration No.: NCT02524483). The participants were pseudo-randomly assigned to 
either a motor adaptation cohort (MAC) or a therapeutic exercise cohort (TEC) upon 
enrollment. The pseudo-random assignments were performed such that a participant 
meeting the inclusion criteria was randomly placed in one of the intervention groups, and 
a second participant with a similar EDSS was assigned to the other group. All 
participants were blinded to therapeutic intervention allocations throughout the study.  
Interventions 
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The total intervention period for both cohorts was six weeks. The therapy was performed 
twice a day for five consecutive days each week. The initial two weeks were conducted 
under close supervision of a physical therapist (HR, BC, or KV). The remaining four 
weeks were performed by the patient at their home and were monitored weekly via 
teleconferences with the therapist. Subjects completed the same activities at home as they 
did during the initial two weeks and kept a home exercise program log book to track their 
activity.  
Motor Adaptation Cohort (MAC) 
	
The motor adaption session included warm-up, balance training, treadmill and 
overground walking training. The warm-up lasted 5 minutes, including several repetitions 
of movements, stretches, and coordination activities for the trunk and limbs.  
    After the warm-up, the participant proceeded with a 20-minute balance-training 
program one-on-one with the therapist according to the initial assessment. The balance 
training program included a sitting/standing balance training, such as sitting on a gym 
ball or standing in a corner with the feet either on the floor or a piece of foam while 
keeping eyes closed. The purpose of this training was to challenge and progress the 
participant’s balance gradually to maintain upright control despite altered visual and 
somatosensory inputs. For instance, the starting position might be less challenging for the 
first 5 minutes on the foam with their feet 10 inches apart, then progressing to more 
challenging positions during next 5-minute periods, and finally returning to a less 
challenging position for the final 5 minutes. During the training, verbal and tactile cues 
were provided for upright posture and relaxation of tense body parts, and verbal cues for 
the increase of sensory awareness (i.e., location of pressure on the soles of feet). The 
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therapist also observed the participant for the ability to meet the task’s demand (i.e., the 
number of touches to the wall). The therapist would increase the demands of postural 
training according to their observations of the participants. In general, no rest periods 
occurred during the balance sessions. During the balance exercises, the participant was 
provided with a table or chair in front for temporary support if necessary, and each 
participant wore a gait belt for balance assistance as needed.  
    Lastly, the participant completed a 20-minute challenging treadmill and overground 
walking training. The treadmill training consisted of tasks such as forward, backward, or 
sideways walking with a harness provided as needed for safety. The use of handrails, the 
degree of ramp incline, and the treadmill speed were tailored to each participant during 
the training to provide an appropriate level of intensity. In addition, the therapist provided 
overground training indoors with varied walking direction, speed, using a less-supportive 
assistive device than they were accustomed to, and/or increasing dynamic balance 
activities. The therapist provided verbal and tactile cues, as well as visual feedback by 
training in front of a mirror to help participants establish a more normal gait pattern. A 
protocol similar to that described above for the balance task was used to progress each 5-
minute locomotor training period. Participants were provided with short rest periods as 
needed. The intensity of the activities was increased as tolerated based on each 
participant’s level of performance and fatigue during the previous session.  
Therapeutic Exercise Cohort (TEC) 
	
Each therapeutic exercise session included 15 minutes of strength and flexibility 
exercises, 15 minutes of balance exercises, and 15 minutes of treadmill walking 
performed in a small group setting (3 subjects). The activities selected for the therapeutic 
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program were similar to those that would be performed in a group exercise program. 
Subjects were instructed to complete each task at their own pace for 3 minutes with the 
therapist supervising. Strength exercises consisted of activities such as forward/backward 
lunges, stepping up/down a step, and squats. Flexibility training was performed both 
standing up and lying on a mat. Subjects were taught how to stretch the lower extremity 
muscles, especially any muscle that was specifically problematic to them. Both static and 
dynamic balance exercises were completed in each session. Static balance exercises 
included standing on a piece of foam with eyes open and feet wide apart, or standing on 
one leg as long as possible with support. Dynamic balance exercises included stepping 
over small obstacles, walking sideways, or walking heel to toe. For treadmill walking, the 
subjects were encouraged to remove one or both hands from the handrails if possible. The 
participants were allowed to increase and decrease their speed as needed to accomplish 
the total time. All subjects reported their rate of perceived exertion based on the Borg 
scale, and were instructed to attempt to work at a score of 12 or 13, which indicates that 
the exercise was somewhat hard. Rest was given as needed throughout the entire session.  
 
Outcome measures & Clinical assessments 
	
For both MAC and TEC, all measurements were assessed at the baseline, as well as at the 
end of week 2 and week 6 of the investigation.  
Balance assessment 
	
The Dynamic Gait Index (DGI) was used to assess dynamic balance while adapting gait 
to changes in task demands, including gait on even surfaces, gait while changing speed, 
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gait while performing head turns, stepping over, or around obstacles, and pivoting during 
walking and stair climbing. The total score ranges from 0 to 24. A high score indicates 
better performance on dynamic balance. A score of 19 or less has been shown to be 
associated with higher risk of falls in MS.35,36 DGI is a reliable tool to assess balance and 
gait dysfunction in persons with MS, with inter-rater reliability ranging from .910 to .976, 
and intra-rater reliability ranging from .760 to .986.35 In this clinical trial, the scoring was 
performed by one researcher (ML) after watching the DGI testing videos in two testing 
sessions 5 days apart.  The test-retest reliability was 0.87, which was calculated by a third 
person (BD).  
Gait assessment 
  
The 12-item Multiple Sclerosis Walking Scale (MSWS-12) is a self-report questionnaire 
to measure the gait ability in individuals with MS. Each item ranges from 1 to 5, 
generating total scores ranging from 12 to 60, or transformed scores ranging from 0-100, 
with the higher the sum indicating more severe ambulatory disability. It is a valid and 
reliable scale in MS.52,53 A study reported that MSWS-12 is significantly correlated with 
spatiotemporal parameters of gait in people with MS, suggesting that it is an easily 
administered and inexpensive tool for the comprehensive assessment of walking 
disability in individuals with MS.54  
Fatigue assessment  
	
The Modified Fatigue Impact Scale (MFIS) was used to evaluate the patients’ fatigue.76 
The MFIS is based on items derived from interviews with patients with MS regarding 
how fatigue impacts their lives. It consists of 21 items, with each item scoring between 0 
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and 4, which gives a self-reported measure of fatigue on physical, cognitive, and 
psychosocial functioning. The MFIS global score range is between 0 and 84, with a 
higher score representing more fatigue. Reliability and validity of the MFIS have been 
established in patient with MS.77 It has been recommended as an outcome measure for 
use in MS research and clinical practice.77 
Quality of Life (QOL) 
	
The Multiple Sclerosis Impact Scale (MSIS-29)90 is twenty-nine item scale to measure 
QOL or impact of MS from the patient’s perspective. It consists of 20 physical items and 
9 psychological items that impact individuals with MS. The MSIS-29 ranges between 29 
and 145, with higher scores indicating greater impact or a poor quality of life. It is a 
reliable and valid measure of disease impact.97 A minimal change of 8 points in the 
MSIS-29 indicates clinical significance.93  
Statistical analysis 
	
Descriptive statistics were used to summarize participant characteristics. Initially, 
independent samples t tests and/or chi-square tests were used to compare the baseline 
characteristics of the MAC and TEC groups. Then, we conducted a series of mixed-
design analysis of variance (ANOVA), which were performed for each outcome measure 
to assess differences across time (2 and 6 weeks) and between study groups, and for the 
interaction between time and study group. For the mixed-design ANOVA, the 
assumptions of sphericity and homogeneity of the variances were tested using Mauchly 
and Levene tests. The Huynh-Feldt correction was applied if there was a violation of the 
sphericity assumption. All statistical analyses were performed using IBM SPSS Statistics 
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22 statistical software (IBM Corp., Armonk, NY, USA). Data were plotted with 
GraphPad PRISM software (GraphPad Software Inc., San Diego, Calif.). Statistical 
significance was set at P≤0.05. Cohen’s d was also used to assess the effect size, which 
was interpreted as small (d= 0.2), medium (d = 0.5), and large (d = 0.8), respectively.98  
 
Results 
	
A total of 43 potential subjects with MS were assessed for eligibility (Figure 1). Ten 
people were excluded because they did not fit the inclusion criteria. The remaining 32 
individuals with relapsing-remitting or secondary progressive MS met the inclusion 
criteria and were assigned to either group. In the MAC, two subjects were withdrawn 
from the study due to noncompliance to the study procedures. In the TEC, one individual 
discontinued due to a non-MS related health condition, and one individual discontinued 
due to a fall-related injury that occurred during the training program. At the end of the 
intervention period, 15 individuals in the MAC (Mean Age ± SD: 52.60 ± 8.72 years, 9 
Females; mean EDSS score, 5.43 ± 0.94) and 13 individuals in the TEC (Mean Age ± 
SD: 54.77 ± 9.27 years, 6 females; mean EDSS ± SD, 5.26 ± 0.95) completed the entire 
six weeks of their respective programs and were included in the analyses. Table 1 
summarizes the characteristics of the subjects between the MAC and TEC at baseline. No 
statistically significant between-group differences for any variables, including age, sex, 
MS type, MS duration, EDSS, MSWS-12, MFIS, and MSIS-29, were found at baseline, 
except DGI (p=0.04). At the end of home-based training, participants from both MAC 
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and TEC had a compliance rate of ≥92%, according to home exercise log book 
information. 
 
Figure 1. Flowchart of enrollment procedure 
 
 
 
 
 
 
 
 
 
 
43	subjects	screened	for	eligibility	
EDSS	and	Mini-Mental	State	Exam	
33	subjects	enrolled	
10	subjects	excluded	
9	–	EDSS	<	3.0	
1	–	unable	to	walk	on	
treadmill	
15	subjects	pseudo-randomly 
assigned	to	the	Therapeutic	Exercise	
2	subjects	discontinued		
-	1	for	non-MS	related	health	
complication	
-	1	for	fall-related	injury	
	
13	subjects	completed	
the	therapy	
18	subjects	pseudo-randomly 
assigned	to	the	Motor	Adaptation	
3	subjects	discontinued		
-	2	for	non-compliance	
-	1	for	non-MS	related	
health	complication		
15	subjects	completed	
the	therapy	
		
	
27	
Table 1 Baseline Characteristics of the Study Participants 
Characteristics  MAC (n=15) TEC (n=13) P-value 
Age (years) 52.60 ± 8.72 54.77 ± 9.27 0.83 
Sex (% female) 46.2% 60% 0.46 
MS type (% RRMS) 69.2% 73.3% 0.81 
MS duration (years) 15.53 ± 6.21 12.23 ± 5.54 0.69 
EDSS 5.43 ± 0.94 5.26 ± 0.95 0.91 
DGI 13.00 ± 3.95 15.85 ± 2.58 0.04* 
MSWS-12 46.53 ± 8.36 41.23 ± 9.40 0.13 
MFIS 71.40 ± 26.59 54.08 ± 42.85 0.20 
MSIS-29 81.13 ± 19.64 71.54 ± 26.98  0.29 
Note: values are mean ± SD or percentage. * Indicates significant difference (p < 0.05) 
Abbreviations: MAC: motor adaption cohort; TEC: therapeutic exercise cohort; MS: 
multiple sclerosis. RRMS, relapsing-remitting multiple sclerosis; EDSS:  Kurtzke 
expanded disability status scale; DGI: dynamic gait index; MSWS-12: 12-item 
multiple sclerosis walking scale; MFIS: modified fatigue impact scale: MSIS-29: 
multiple sclerosis impact scale.  
 
Balance measures 
	
There was a significant pre/post main effect (increase in the composite DGI scores) from 
baseline to the end of 2-week training (14.42 ± 3.39 vs. 17.53 ± 3.13, respectively) (p < 
0.001; Cohen’s d = 0.95), as well as from baseline to the end of 6-week training (14.42 ± 
3.39 vs. 18.62 ± 2.77, respectively) (p <0.001, Cohen’s d = 1.36) (Fig 2, Table 2). 
Moreover, there was a statistically significant difference regarding the composite DGI 
score between 2-week training and 6-week training (17.53 ± 3.13 vs. 18.62 ± 2.77, 
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respectively)  (p = 0.001, Cohen’s d = 0.37). However, there was no significant 
interaction between time and group (p = 0.243), indicating both groups improved their 
dynamic balance similarly (Fig 2).  
 
 Figure 2: Mean changes in the DGI raw score at 2 and 6 weeks. DGI: Dynamic Gait Index; TEC: 
Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 0.05 
Table 2: Outcome measures for all participants before and after receiving MAC or TEC (Mean, SD, and 
95% CI) 
Outcome Baselin
e level, 
mean 
(SD) 
2-week 
level, 
mean 
(SD)  
  
6-week 
level, 
mean 
(SD) 
2-week post-
intervention 
effects (change 
from the baseline) 
6-week post-
intervention 
effects (change 
from the baseline) 
6-week post-
intervention 
effects (change 
from the 2-week) 
Mean 
differenc
e (95% 
CI) 
P value  Mean 
differenc
e (95% 
CI) 
P value Mean 
differenc
e (95% 
CI)  
P 
value 
DGI (range, 0-24) 
MAC 
(n=15) 
13.00 
(3.95) 
16.67 
(3.24) 
18.00 
(2.73) 
      
TEC 
(n=13) 
15.85 
(2.57) 
18.38 
(2.99) 
19.23 
(2.77) 
      
Composit
e result 
14.42 
(3.39) 
17.53 
(3.13) 
18.62 
(2.77) 
3.10 
(1.70, 
4.51) 
<0.001
* 
4.192 
(2.72, 
5.67) 
<0.001
* 
1.09 
(0.40, 
1.78) 
0.001
* 
MSWS-12 (range, 12-60) 
MAC 
(n=15) 
46.53 
(8.36) 
35.00 
(11.83) 
32.20 
(8.74) 
      
TEC 
(n=13) 
41.23 
(9.40) 
34.85 
(8.51) 
30.92 
(7.85) 
      
Composit
e result 
43.88 
(8.87) 
34.92 
(10.46) 
31.56 
(8.37) 
-8.96 (-
13.65, -
4.27) 
<0.001
* 
-12.32 (-
16.50, -
8.14) 
<0.001
* 
-3.36 (-
7.17, -
0.45) 
0.097 
MFIS (range, 0-84) 
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MAC 
(n=15) 
71.40 
(26.59) 
43.60 
(26.00) 
36.07 
(21.79) 
      
TEC 
(n=13) 
54.08 
(42.85) 
39.54 
(25.69) 
24.46 
(17.61) 
      
Composit
e result 
62.74 
(35.14) 
41.57 
(25.92) 
30.26 
(20.02) 
-21.17 (-
32.39, -
9.95) 
<0.001
* 
-32.47 (-
47.33, -
17.62) 
<0.001
* 
-11.31 (-
20.45, -
2.16) 
0.012
* 
MSIS-29 (range, 29-145) 
MAC 
(n=15) 
81.13 
(19.64) 
60.20 
(16.47) 
59.27 
(18.06) 
      
TEC 
(n=13) 
71.54 
(26.98) 
54.69 
(14.31) 
52.61 
(12.51) 
      
Composit
e result 
76.34 
(23.38) 
57.45 
(15.55) 
55.94 
(15.78) 
-18.89 (-
27.84, -
9.94) 
<0.001
* 
-20.40 (-
30.95, -
9.84) 
<0.001
* 
-1.51 (-
8.51, 
5.50) 
1.000 
* Indicates significant difference (p < 0.05) 
Abbreviations: MAC: motor adaption cohort; TEC: therapeutic exercise cohort; MS: multiple sclerosis. 
DGI: dynamic gait index; MSWS-12: 12-item multiple sclerosis walking scale; MFIS: modified fatigue 
impact scale: MSIS-29: multiple sclerosis impact scale. 
 
Gait measures 
	
There was a significant pre/post main effect (decrease in the composite MSWS-12 
scores) from baseline to the end of 2-week training (43.88 ± 8.87 vs. 34.92 ± 10.46, 
respectively) (p < 0.001, Cohen’s d = 0.92), as well as from baseline to the end of 6-week 
training (43.88 ± 8.87 vs. 31.56 ± 8.37, respectively) (p <0.001, Cohen’s d = 1.43) (Fig 3, 
Table 2). There was no statistically significant difference in the composite MSWS-12 
score between 2-week training and 6-week training (34.92 ± 10.46 vs. 31.56 ± 8.37, 
respectively) (p =0.097, Cohen’s d = 0.35). And there was no significant interaction 
between time and group (p = 0.272), suggesting both groups improved their self-reported 
gait ability similarly (Fig 3).  
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Figure 3: Mean changes in the MSWS-12 raw score at 2 and 6 weeks. MSWS-12: Multiple Sclerosis 
Walking Scale-12; TEC: Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 
0.05 
 
Fatigue measures  
	
There was a statistically significant pre/post main effect (decrease in composite MFIS) 
from baseline to 2-week training (62.74 ± 35.14 vs. 41.57 ± 25.92, respectively) (p < 
0.001, Cohen’s d = 0.69) and 6-week training (62.74 ± 35.14 vs. 30.26 ± 20.02, 
respectively) (p < 0.001, Cohen’s d = 1.14) (Fig 4, Table 2). And there was a significant 
difference of the composite MFIS between 2-week training and 6-week training (41.57 ± 
25.92 vs. 30.26 ± 20.02, respectively) (p = 0.012, Cohen’s d = 0.49). However, there was 
no significant interaction between time and group (p = 0.371), indicating both groups 
improved their fatigue (Fig 4).  
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Figure 4: Mean changes in the MFIS raw score at 2 and 6 weeks. MFIS: Modified Fatigue Impact Score; 
TEC: Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 0.05 
 
QOL measures  
	
There was a significant pre/post main effect (decrease in the composite MSIS-29 scores) 
from baseline to the end of 2-week training (76.34 ± 23.38 vs. 57.45 ± 15.55, 
respectively) (p < 0.001, Cohen’s d = 0.95), as well as from baseline to the end of 6-week 
training (76.34 ± 23.38 vs. 55.94 ± 15.78, respectively) (p < 0.001, Cohen’s d = 1.02) 
(Fig 5, Table 2). There was no statistically significant difference regarding the composite 
MSIS-29 between 2-week training and 6-week training (57.45 ± 15.55 vs. 55.94 ± 15.78, 
respectively)  (p = 1.000, Cohen’s d = 0.10). And there was no significant interaction 
between time and group (p = 0.835), suggesting both groups improved their QOL 
similarly (Fig 5).  
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Figure 5: Mean changes in the MSIS-29 raw score at 2 and 6 weeks. MSIS-29: Multiple Sclerosis Impact 
Scale; TEC: Traditional Exercise Cohort; MAC: Motor Adaptation Cohort. * indicates p < 0.05 
 
Discussion 
	
Our pseudorandomized clinical trial showed that both MAC and TEC groups improved 
the balance, gait, fatigue, and QOL in people with MS in a clinically relevant manner. 
However, no significant differences were observed between improvements in MAC 
group as compared to the TEC group.  This effect was evident in the assessment tools, 
including DGI, MSWS-12, MFIS, and MSIS-29. The effect was also consistent with the 
assessments in our previous study showing the benefits of the high-frequency physical 
therapy regarding postural balance and mobility in people with MS.21 Based on the 
Cohen’s d criteria, our data suggest a large effect size of improvement in balance, gait, 
and QOL, as well as medium effect size of improvement in fatigue only after 2 weeks of 
intervention. It also indicates a large effect size of improvement in all outcome measures 
after 6 weeks of high-frequency physical therapy.  
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Effects on Dynamic Balance  
A statistically significant, but a comparable improvement over time at 2-week and 6-
week periods was observed for dynamic balance according to DGI scores in MAC and 
TEC groups. This is contradictory to our hypothesis that the subjects in the MAC would 
have greater improvements in the balance than those in the TEC. The minimal detectable 
change (MDC) for the DGI is between 4.19 and 5.54 in people with MS.37 Based on this 
standard, the composite group at 6 weeks showed a detectable change of DGI score 
(mean difference: 4.2 points). The minimal clinically important difference (MCID) has 
not been established for MS patients so far.  The trend towards improvement of DGI 
scores in both groups slowed down after the second week (Fig 1B). We suspect that 
participants in both groups would have greater improvements in DGI scores if we 
provided them continuing one-on-one training with the physical therapists. Even though 
the compliance rate for the both groups was ≥92%, it may have been difficult for 
participants to achieve the same effects of the one-on-one training with the therapists 
after the second week, especially for the subjects in the MAC, as it required them to 
properly adjust the different levels of exercises themselves.  
Effects on Gait  
The subjects in the study demonstrated a similar significant decrease of 14.33 (30.80%) 
and 10.31 (25.01%) points (percentage change) in MSWS-12 at 6-week period in MAC 
and TEC groups respectively. This is evident by our DGI findings, as the DGI is also a 
clinical tool to assess gait performance in response to changing task demands. Moreover, 
it is consistent with our previous result that both MAC and TEC group had similar 
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significant improvements in the walking speed and step length in patients with MS.21 
There is no MCID established for the MSWS-12, but a study reported the minimal 
detectable change (MDC) for the measure was 22 points.99 Although it indicates the 
participants’ perception of the change would not be likely to represent a true change in 
their gait ability, we suspect that a greater or true improvement would be achieved if our 
participants would have continued one-on-one training with the physical therapists after 
the second week.  
Effects on Fatigue  
Fatigue was significantly diminished in both groups, with a 35.33-point (49.48%) 
decrease in MAC and a 29.62-point (54.77%) decrease (percentage change) in TEC with 
regards to the MFIS total score at the 6-week period. To our knowledge, this is the first 
study to demonstrate that the high-frequency physical therapy protocols are beneficial to 
improve fatigue in patients with MS. The beneficial effects also exceeded previous 
reports from various rehabilitation studies: 55 minutes per session, twice weekly, 6-week 
vestibular program (21.5 points, p<0.001),100 30  minutes per session, 3 times weekly, 12-
week supported treadmill program (13.3 points, p=0.22),101 and 40 minutes per session, 3 
times weekly, 12-week mixed exercise program (13.0 points, p=0.02).102 The minimal 
detectable change (MDC) for the MFIS was found to be 19.23%,103 while our study 
showed an improvement of 49.38% and 54.77% in MAC and TEC at 6 weeks 
respectively, suggesting our high-frequency physical therapy protocols may have resulted 
in clinically important changes in fatigue as measured by the MFIS. Fatigue is one of the 
major factors affecting people with MS. Fatigue can worsen MS other MS-related 
symptoms and lead to increased risk of falls. The cause of fatigue in MS is most likely 
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multifactorial, including axonal degeneration, demyelination, depression, and physical 
inactivity.104 There is cumulating evidence demonstrating that exercise intervention is 
safe and it has significant reductions in fatigue in people with MS.20,24 Improvements in 
fatigue from our high-frequency physical therapy protocols may result from 
improvements in balance, walking ability, and psychosocial variables, such as depression 
and mood. Consequently, participants may be able to perform daily tasks in a more 
efficient manner at relatively lower intensities, which results in energy conservation and 
fatigue improvement.  
Effects on QOL 
In this study, total MSIS-29 score showed statistically significant improvement for both 
groups, but no significant interaction effect between group and time. The MCID values 
have not been established for the MSIS-29, but the MDC has been reported to be 8 
points.93 The subjects in this study had a mean change of 20.93 (MAC) and 16.85 (TEC) 
points in the MSIS-29 after 2-weeks of training with therapists, indicating the 
participants’ perception represent a true improvement of the score. However, there was a 
minimal improvement of the score during the 4-week home-based training for both 
groups. It could be due to the lack of motivation and encouragement directly from 
therapists and other participants at home, even though the compliance rate for the home-
based training was relatively high for both groups (≥92%). There has been cumulative 
evidence to support that physical activity is associated with the improvement of QOL in 
patients with MS.95 Several factors have been proposed to be mediators of the physical 
activity on QOL in MS, such as physical function, fatigue, mood, and social support.94 
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Our high-frequency physical therapy protocol may improve QOL in MS through its 
effects on the previous factors and it remains to be explored in future studies.  
    This study was designed to test if our motor adaptation therapy protocol would yield 
better improvements in balance, gait, fatigue, and QOL in people with MS compared with 
the therapeutic exercise protocol. After 6-week intervention, both groups showed 
significant improvements in balance, gait, fatigue, and QOL, however, no interaction 
effects between group and time were found for the aforementioned factors. Since both 
cohorts completed different training protocols at the same frequency, a high-frequency 
physical therapy protocol might be an effective and efficient dosage parameter for the 
rehabilitation of individuals with MS.  
Limitations 
	
There are a few limitations in the present study. First, our clinical investigation was based 
on a relatively small sample size to differentiate the treatment effects between the two 
groups. However, the large effect size of the improvements in clinical measures suggests 
that the findings are less likely to be affected by sample size. A larger sample size could 
improve the generalizability of our findings. Second, there is variability in the level of 
disability of participants with MS from moderate to severe. We limited the subjects’ 
EDSS from 3.0 to 6.5. There was no significant difference between two groups with 
regard to the participants’ mean score of the EDSS at baseline.  However, a more 
homogenous subset of participants according to the severity of disability may have 
produced different outcomes. And the benefits of high-frequency physical therapy 
training for patients with more severe disability (EDSS > 6.5) require further 
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investigation. Third, there is a lack of a controlled group trained at a normal-dosage or 
less-frequent physical therapy.  It would be of help to explore if the high frequency of the 
physical therapy has a ceiling effect, or if there is a different treatment effect between two 
different protocols at a typical-dosage level of physical therapy. Finally, we did not 
perform a follow-up study to determine whether the treatment effect would maintain after 
the intervention. Subsequent investigations on long-term effectiveness of the high-
frequency physical therapy in people with MS would be desirable.  
Conclusions 
	
Our study shows both motor adaptation exercises and traditional exercises had a 
significant, but similar treatment effect for primary outcomes after 6-week physical 
therapy intervention. Our results provide evidence that a high-frequency physical therapy 
intervention consisting of twice per day and five days per week sessions may be an 
important parameter for improving balance, gait, fatigue, and QOL in people with MS.  
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